Recurrent Respiratory Papillomatosis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Aliases & Classifications for Recurrent Respiratory Papillomatosis

Sources:
⁴⁰MESH via Orphanet, ⁴⁸NIH Rare Diseases, ⁵⁴Orphanet, ⁶⁸UMLS, ⁶⁹UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Recurrent Respiratory Papillomatosis:

Name: Recurrent Respiratory Papillomatosis ⁴⁸ ⁵⁴ ⁶⁸

Juvenile-Onset Recurrent Respiratory Papillomatosis ⁴⁸

Adult-Onset Recurrent Respiratory Papillomatosis ⁴⁸

Respiratory Papillomatosis, Recurrent ⁴⁸

Laryngeal Papilloma, Recurrent ⁴⁸

Juvenile Laryngeal Papilloma ⁴⁸

Jorrp ⁴⁸

Aorrp ⁴⁸

Rrp ⁴⁸

Characteristics:

Orphanet epidemiological data:

⁵⁴

recurrent respiratory papillomatosis:
Age of onset: Adolescent,Adult,Childhood

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Respiratory diseases

See all MalaCards categories (disease lists)

Orphanet: ⁵⁴

Rare respiratory diseases

External Ids:

Orphanet⁵⁴ ORPHA60032

UMLS via Orphanet⁶⁹ C1168198

MESH via Orphanet⁴⁰ C535297

Summaries for Recurrent Respiratory Papillomatosis

Sources:
³⁶MalaCards, ⁴⁸NIH Rare Diseases
See all MalaCards sources

NIH Rare Diseases:⁴⁸ Recurrent respiratory papillomatosis (rrp) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). although the tumors can grow anywhere in the respiratory tract, their presence in the larynx (voice box) causes the most frequent problems, a condition called laryngeal papillomatosis. the tumors may vary in size and grow very quickly. they often grow back even when removed. rrp is caused by two types of human papillomavirus (hpv), called hpv 6 and hpv 11. last updated: 11/21/2011

MalaCards based summary: Recurrent Respiratory Papillomatosis, also known as juvenile-onset recurrent respiratory papillomatosis, is related to laryngeal papillomatosis and apple allergy. An important gene associated with Recurrent Respiratory Papillomatosis is HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1), and among its related pathways are CTLA4 Signaling and Staphylococcus aureus infection. Affiliated tissues include lung, t cells and testes.

Related Diseases for Recurrent Respiratory Papillomatosis

Sources:
²⁰GeneAnalytics, ²¹GeneCards
See all MalaCards sources

Diseases related to Recurrent Respiratory Papillomatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 59)

id	Related Disease	Score	Top Affiliating Genes
1	laryngeal papillomatosis	11.1
2	apple allergy	10.2	HLA-DQB1, HLA-DRB1
3	hemoglobin d disease	10.2	HLA-DQB1, HLA-DRB1
4	bilateral parasagittal parieto-occipital polymicrogyria	10.2	HLA-DQB1, HLA-DRB1
5	immune deficiency, familial variable	10.2	HLA-DQB1, HLA-DRB1
6	lin-gettig syndrome	10.2	HLA-DQB1, HLA-DRB1
7	midline interhemispheric variant of holoprosencephaly	10.2	HLA-DQB1, HLA-DRB1
8	autosomal dominant intermediate charcot-marie-tooth	10.2	HLA-DQB1, HLA-DRB1
9	lyme disease - neurological complications	10.2	HLA-DQB1, HLA-DRB1
10	distal trisomy 14q	10.2	HLA-DQB1, HLA-DRB1
11	learning disability	10.2	HLA-DQB1, HLA-DRB1
12	papilloma	10.2
13	linear lichen planus	10.2	HLA-DQB1, HLA-DRB1
14	caplan's syndrome	10.2	HLA-DRB1, IL2
15	night blindness	10.2	HLA-DQB1, HLA-DRB1
16	cervical adenoid basal carcinoma	10.2	HLA-DQB1, HLA-DRB1
17	neonatal antiphospholipid syndrome	10.2	HLA-DQB1, HLA-DRB1
18	myofibroma	10.2	HLA-DQB1, HLA-DRB1
19	oromandibular dystonia	10.2	HLA-DQB1, HLA-DRB1
20	cryptococcosis	10.2	HLA-DQB1, HLA-DRB1
21	bickerstaff brainstem encephalitis	10.2	HLA-DQB1, HLA-DRB1
22	cerebral sarcoidosis	10.2	HLA-DRB1, IL2
23	hepatitis	10.1	HLA-DRB1, IL2
24	squamous cell carcinoma	10.1
25	low anorectal malformation	10.1	HLA-DQB1, HLA-DRB1
26	endogenous depression	10.1	HLA-DRB1, IL2
27	ragweed sensitivity	10.1	HLA-DQB1, HLA-DRB1
28	folinic acid-responsive seizures	10.1	HLA-DQB1, HLA-DRB1
29	familial acute necrotizing encephalopathy	10.1	HLA-DRB1, IFNA2
30	lymphangiectasia, intestinal	10.1	HLA-DQB1, HLA-DRB1
31	diffuse scleroderma	10.1	HLA-DRB1, IL2
32	clostridium difficile colitis	10.0	HLA-DQB1, HLA-DRB1, IL2
33	multinodular goiter	10.0	EGFR, IL2
34	heart conduction disease	10.0	HLA-DRB1, IL2
35	benign familial neonatal epilepsy	10.0	EGFR, IFNA2
36	oropharynx cancer	10.0	IFNA2, IL2
37	laryngitis	10.0
38	advanced sleep phase syndrome, familial, 1	10.0	HLA-DQB1, HLA-DRB1, IL2
39	myxedema	10.0	EGFR, IFNA2
40	anaerobic meningitis	10.0	EGFR, HLA-DQB1, HLA-DRB1
41	choreatic disease	10.0	HLA-DQB1, HLA-DRB1
42	anterior corneal pigmentation	10.0	HLA-DQB1, HLA-DRB1, IFNA2
43	anterior foramen magnum meningioma	9.9	IFNA2, IL2
44	parasitic helminthiasis infectious disease	9.9	HLA-DQB1, HLA-DRB1
45	ovarian brenner tumor	9.9	EGFR, IFNA2, IL2
46	gastroesophageal reflux	9.9
47	epidermodysplasia verruciformis	9.8
48	lung cancer	9.7
49	asthma	9.7
50	aspergillosis	9.7

Graphical network of the top 20 diseases related to Recurrent Respiratory Papillomatosis:

Symptoms & Phenotypes for Recurrent Respiratory Papillomatosis

Drugs & Therapeutics for Recurrent Respiratory Papillomatosis

Sources:
¹BitterDB, ⁴ClinicalTrials, ¹⁰DGIdb, ¹⁴DrugBank, ²⁹HMDB, ³³IUPHAR, ⁵⁰Novoseek, ⁵⁶PharmGKB
See all MalaCards sources

Drugs for Recurrent Respiratory Papillomatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)

id

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Cidofovir

approved

Phase 4, Phase 2

33

113852-37-2

60613

Synonyms:

(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine

(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid

(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine

(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine

(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid

(S)-HPMPC

(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid

({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid

({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid

1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine

1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate

1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

113852-37-2

120362-37-0 (hydrochloride salt)

149394-66-1

AC-1666

AC1L1TLB

AC1Q6C68

AKOS005145721

C8H14N3O6P

CDV

CHEBI:3696

CHEMBL152

CID60613

Cidofovir

Cidofovir (Vistide)

Cidofovir (anhydrous)

Cidofovir Anhydrous

Cidofovir anhydrous

Cidofovirum

DB00369

Forvade

GS 0504

GS 504

GS-0504

GS-504

GS504

HPMPC

HSDB 7115

LS-106432

MolPort-005-935-597

NSC742135

S1516_Selleck

UNII-768M1V522C

Vistide

Vistide, Cidofovir

[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid

[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid

[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid

2

Antiviral Agents

Phase 4, Phase 3, Phase 2

9967

3

Anti-Infective Agents

Phase 4, Phase 2

22062

4

Vaccines

Phase 3, Early Phase 1

6611

5

Antibodies

Phase 3, Phase 2

6394

6

Immunoglobulins

Phase 3, Phase 2

6394

7

Bevacizumab

approved, investigational

Phase 2, Phase 1

2020

216974-75-3

Synonyms:

216974-75-3

Avastin

Avastin (TN)

Bevacizumab

Bevacizumab (genetical recombination)

Bevacizumab (genetical recombination) (JAN)

D06409

R-435

anti-VEGF monoclonal antibody

antiVEGF

bevacizumab

8

Celecoxib

approved, investigational

Phase 2

444

169590-42-5

2662

Synonyms:

169590-42-5

184007-95-2

1oq5

4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide

4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide

4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

AC-4228

AC1L1E6K

AI-525

BIDD:GT0408

BRD-K02637541-001-02-4

BSPBio_003596

Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)

C07589

C105934

C17H14F3N3O2S

CCRIS 8679

CEL

CEP-33222

CHEBI:41423

CHEMBL118

CID2662

CPD000550473

Celebra

Celebrex

Celebrex (TN)

Celebrex, Celebra, Celecoxib

Celecox

Celecoxi

Celecoxib

Celecoxib (JAN/USAN/INN)

Celecoxib (SC-58635)

Celecoxib [Old RN]

Celecoxib [USAN]

Celecoxibum

Celocoxib

Célécoxib

D00567

DB00482

DivK1c_000893

Eurocox

FT-0080064

HMS1922G14

HMS2089L18

HMS2093I07

HMS502M15

HSDB 7038

I01-1033

IDI1_000893

KBio1_000893

KBio2_000912

KBio2_002351

KBio2_003480

KBio2_004919

KBio2_006048

KBio2_007487

KBio3_002830

KBio3_003037

KBioGR_000723

KBioGR_002351

KBioSS_000912

KBioSS_002354

LS-31667

MLS001165684

MLS001195656

MLS001304708

Medicoxib

MolPort-002-885-815

NCGC00091455-01

NCGC00091455-02

NCGC00091455-03

NCGC00091455-04

NCI60_041049

NINDS_000893

NSC719627

Onsenal

P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide

Pfizer brand of celecoxib

S1261_Selleck

SAM002589995

SC 58635

SC-58553, SC-58635

SC-58635

SC58635

SMR000550473

SPBio_001512

SPECTRUM1503678

Solexa

Spectrum2_001576

Spectrum3_001996

Spectrum4_000182

Spectrum5_001324

Spectrum_000432

TL8001323

TPI-336

UNM-0000305813

Xilebao

YM 177

YM-177

YM177

ZINC02570895

cMAP_000027

celecoxib

p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide

9

Pembrolizumab

approved

Phase 2

507

1374853-91-4

Synonyms:

Keytruda

MK-3475

lambrolizumab

10

Vitamin A

approved, nutraceutical, vet_approved

Phase 2

492

11103-57-4, 68-26-8

445354

Synonyms:

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol

(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol

.alpha.lin

.alpha.sterol

.beta.-Retinol

11103-57-4

13123-33-6

1341-18-0

1406-67-3

17104-91-5

1rbp

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol

3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer

4-06-00-04133 (Beilstein Handbook Reference)

53637-36-8

5979-23-7

68-26-8

95144_FLUKA

95144_SIGMA

95146_FLUKA

95146_SIGMA

A-Mulsal

A-Sol

A-Vi-Pel

A-Vitan

AC-11701

AC1L9HU3

AC1Q7BU9

ACON

ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)

AR-1L3057

ATAV

Afaxin

Agiolan

Agoncal

Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol

Alcovit A

All Trans Retinol

All-trans retinol

All-trans-Retinol

Alphalin

Alphasterol

Anatola

Anatola A

Anti-infective vitamin

Antixerophthalmic vitamin

Antixerophthalmisches Vitamin

Aoral

Apexol

Apostavit

Aquasol A Parenteral

Aquasynth

Atars

Avibon

Avita

Avitol

Axerol

Axerophthol

Axerophtholum

BIDD:PXR0102

BRN 0403040

Bentavit A

Biosterol

C00473

C17276

C20H30O

CCRIS 5444

CHEBI:17336

CHEMBL986

CID445354

Chocola A

Cylasphere

D014801

D06543

DB00162

Del-VI-A

Disatabs Tabs

Dofsol

Dohyfral A

EINECS 200-683-7

EINECS 234-328-2

Epiteliol

HMS1921B04

HMS2092L13

HMS501I08

HSDB 815

Hi-A-Vita

Homagenets Aoral

Homagenets aorl

Hydrovit A

IDI1_000486

LMPR01090001

LPK

LS-1578

Lard Factor

M.V.C. 9+3

M.V.I.-12

MLS001066379

MLS001074751

MolPort-001-785-962

Mvc Plus

Myvpack

NCGC00091784-01

NCGC00091784-02

NCGC00091784-03

NCGC00091784-04

NCGC00091784-05

NCGC00091784-06

NSC 122759

NSC122759

Nio-A-Let

Oleovitamin A

Ophthalamin

Plivit A

Prepalin

R7632_SIGMA

Retin-11,12-t2-ol (9CI)

Retinol

Retinol [INN:BAN]

Retinol solution

Retinol, all-trans- (8CI)

Retinol-(cellular-retinol-binding-protein)

Retinolo

Retinolo [DCIT]

Retinolum

Retinolum [INN-Latin]

Retrovitamin A

Ro-a-vit

Rovimix A 500

SDCCGMLS-0066724.P001

SMP2_000102

SMR000112036

SPECTRUM1501203

ST057232

Sehkraft A

Solu-A

Spectrum5_000993

Spectrum5_001997

Super A

Testavol

Testavol S

Thalasphere

UNII-81G40H8B0T

UNII-G2SH0XKK91

Vaflol

Vafol

Veroftal

Vi-.alpha.

Vi-Alpha

Vi-Dom-A

Vi-a

Vio-A

Vitamin A

Vitamin A (Feed)

Vitamin A (USP)

Vitamin A alcohol

Vitamin A alcohol (VAN)

Vitamin A cryst

Vitamin A1

Vitamin A1 alcohol

Vitamin A1 alcohol, all trans

Vitamin- A

Vitamin- A alcohol

Vitamin- A alcohol solution

Vitamin- A1

Vitamin-?A

Vitamin-?A alcohol

Vitamin-?A alcohol solution

Vitamin-?A1

Vitamine A

Vitaminum A

Vitavel A

Vitavel-A

Vitpex

Vogan

Vogan-Neu

Vogan-nu

WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1

Wachstumsvitamin

ZINC03831417

Zinosan N

[11,12-3H]-Retinol

alin

all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol

all-trans-Retinol

all-trans-Retinyl alcohol

all-trans-Vitamin A

all-trans-Vitamin A alcohol

all-trans-Vitamin A1

all-trans-retinol

all-trans-retinyl alcohol

all-trans-vitamin A alcohol

b-Retinol

beta-Retinol

retinol

tROL

trans-Retinol

trans-Retinol acid (Vitamin A)

trans-Vitamin A alcohol

trans-retinol

11

Peripheral Nervous System Agents

Phase 2

23689

12

Angiogenesis Inhibitors

Phase 2, Phase 1

4257

13

Cyclooxygenase Inhibitors

Phase 2

2870

14

Angiogenesis Modulating Agents

Phase 2, Phase 1

4185

15

Analgesics, Non-Narcotic

Phase 2

6501

16

Cyclooxygenase 2 Inhibitors

Phase 2

624

17

Anti-Inflammatory Agents

Phase 2

10729

18

Analgesics

Phase 2

11733

19

Anti-Inflammatory Agents, Non-Steroidal

Phase 2

4443

20

Antirheumatic Agents

Phase 2

10956

21

Pharmaceutical Solutions

Phase 2

8192

22

Antibodies, Monoclonal

Phase 2

4039

23

Retinol palmitate

Phase 2

492

24

retinol

Nutraceutical

Phase 2

492

25

Ergocalciferol

approved, nutraceutical

Phase 1

1281

50-14-6

5280793

Synonyms:

'Ergosterol irradiated'

(+)-Vitamin D2

(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol

(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol

(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol

(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol

(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol

31316-19-5

4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol

47768_SUPELCO

50-14-6

7489-18-1

7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87

8017-28-5

9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol

9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol

9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol

9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol

95220_FLUKA

95220_SIGMA

AC-1355

AC1L1FIE

AC1NQXLH

AC1NS4DE

AC1NS9GI

AC1NSSVD

AC1NWAM3

AC1O5EDK

AC1O6WAM

ACon1_002187

Activated ergosterol

BPBio1_000418

BSPBio_000380

BSPBio_001974

Buco-D

C05441

C28H44O

CALCIFEROL IN A GELATIN MATRIX

CALCIFEROL, U.S.P.

CHEBI:28934

CHEMBL1536

CID11003810

CID3249

CID5280793

CID5315257

CID5353610

CID5356615

CID5702050

CID6432478

CID6536972

Calciferol

Calciferol (TN)

Calciferol (vitamin D2)

Calciferolum

Calciferon 2

Condacaps

Condocaps

Condol

Crtron

Crystallina

D-Arthin

D-Tracetten

D00187

DB00153

Daral

Davitamon D

Davitin

De-rat concentrate

Decaps

Dee-Osterol

Dee-Ron

Dee-Ronal

Dee-Roual

Deltalin

Deratol

Detalup

Diactol

Divit urto

Doral

Drisdol

Drisdol (TN)

E5750_SIGMA

EINECS 200-014-9

Ercalciol

Ergocalciferol

Ergocalciferol (D2)

Ergocalciferol (JP15/USP)

Ergocalciferol [INN:BAN:JAN]

Ergocalciferol oil

Ergocalciferol: Vitamin D

Ergocalciferolo

Ergocalciferolo [DCIT]

Ergocalciferols

Ergocalciferolum

Ergocalciferolum [INN-Latin]

Ergorone

Ergosterol activated

Ergosterol irradiated

Ergosterol, irradiated

Ertron

Fortodyl

Geltabs

Geltabs Vitamin D

HMS1920K20

HMS2091B19

HMS502I07

HSDB 819

Haliver

Hi-Deratol

Hyperkil

I05-0022

IDI1_000805

Infron

Irradiated ergosta-5,7,22-trien-3-beta-ol

Irradiated ergosta-5,7,22-trien-3.beta.-ol

Irradiated ergosta-5,7,22-trien-3beta-ol

Irradiated ergosterol

LMST03010001

LMST03010014

LS-3228

MEGxm0_000466

MLS001332467

MLS001332468

Metadee

Mina D2

MolPort-001-740-057

MolPort-001-793-930

MolPort-002-526-645

MolPort-003-666-178

MolPort-006-822-629

Mulsiferol

Mykostin

NCGC00142497-01

NCGC00179579-01

NCGC00179579-02

NSC 62792

NSC62792

Novovitamin-D

Oleovitamin D

Oleovitamin D, Synthetic

Oleovitamin D2

Osteil

Ostelin

Prestwick3_000420

Prestwick_554

Radiostol

Radstein

Radsterin

Rodine C

Rodinec

SMR000857106

SPECTRUM1500276

ST057150

STOCK1N-53397

Shock-ferol

Shock-ferol sterogyl

Sorex C.R

Sorex C.R.

Spectrum5_000666

Sterogyl

Synthetic Vitamin D

UNII-VS041H42XC

Uvesterol D

Uvesterol-D

VITAMIN D2

VITAMIN D2 WATER DISPERSABLE U.S.P.

VITAMIN_D2

Vigantol

Vio D

Vio-D

Viostdrol

Viosterol

Viosterol in Oil

Vitamin D2

Vitamin- D2

Vitamin-?D2

Vitamina D2

Vitavel-D

WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ

ZINC04474571

ZINC04629876

beta-Ol

bmse000510

component of Geltabs Vitamin D

delta-Arthin

delta-Tracetten

ergocalciferol

vitamin d-2

26

Trace Elements

Phase 1

6001

27

vitamin d

Phase 1

1724

28

Micronutrients

Phase 1

6001

29

Bone Density Conservation Agents

Phase 1

3376

30

Vitamins

Phase 1

5282

31

Ergocalciferols

Phase 1

1281

32

Calciferol

Nutraceutical

Phase 1

1383

33

Vitamin D2

Nutraceutical

Phase 1

1281

34

Pepsin A

15

Interventional clinical trials:

(show all 20)

id	Name	Status	NCT ID	Phase
1	Use of Cidofovir for Recurrent Respiratory Papillomatosis	Completed	NCT00205374	Phase 4
2	Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")	Terminated	NCT00747461	Phase 4
3	4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children	Unknown status	NCT01995721	Phase 3
4	Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis	Active, not recruiting	NCT01375868	Phase 3
5	Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis	Withdrawn	NCT01058317	Phase 2, Phase 3
6	Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis	Completed	NCT00571701	Phase 2
7	A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis	Completed	NCT00038714	Phase 2
8	Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis	Recruiting	NCT02555800	Phase 2
9	Avelumab for People With Recurrent Respiratory Papillomatosis	Recruiting	NCT02859454	Phase 2
10	Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement	Recruiting	NCT02632344	Phase 2
11	Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)	Completed	NCT01020747	Phase 1
12	Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)	Not yet recruiting	NCT02854761	Phase 1
13	Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease	Withdrawn	NCT00733252	Phase 1
14	Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP	Completed	NCT00550914
15	Human Papillomatosis Genotyping of Children in Thailand	Completed	NCT01304966
16	Human Papillomavirus 6/11 in the Lower Airway of Neonates	Completed	NCT00549250
17	Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions	Completed	NCT02217358
18	Recurrent Respiratory Papillomatosis and Extraesophageal Reflux	Recruiting	NCT02592902
19	New Therapy of Laryngeal Papilloma In Children	Terminated	NCT00591305
20	Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis	Withdrawn	NCT00829608	Early Phase 1

Search NIH Clinical Center for Recurrent Respiratory Papillomatosis

Genetic Tests for Recurrent Respiratory Papillomatosis

Anatomical Context for Recurrent Respiratory Papillomatosis

Sources:
³⁶MalaCards
See all MalaCards sources

MalaCards organs/tissues related to Recurrent Respiratory Papillomatosis:

³⁶

Lung, T cells, Testes, Trachea, Spinal cord

Publications for Recurrent Respiratory Papillomatosis

Sources:
⁵⁷PubMed
See all MalaCards sources

Articles related to Recurrent Respiratory Papillomatosis:

(show top 50) (show all 368)

id	Title	Authors	Year
1	Validation of the Distress Thermometer and Problem List in Patients with Recurrent Respiratory Papillomatosis. (27600632)	San Giorgi M.R.... Dikkers F.G.	2016
2	Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan. (26860235)	Murono S.... Yoshizaki T.	2016
3	Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates. (27074766)	Novakovic D.... Brotherton J.M.	2016
4	Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report. (27863633)	Baumanis M.M.... Elmaraghy C.A.	2016
5	Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis. (26968061)	Hermann J.S.... Nagata Pignatari S.S.	2016
6	Impaired T Cell-dependent Humoral Immune Response Associated with Juvenile-onset Recurrent Respiratory Papillomatosis Progression. (27821867)	Wu X.... Ni X.	2016
7	Is recurrent respiratory papillomatosis a manageable or curable disease? (26608928)	Kim H.T.... Baizhumanova A.S.	2016
8	Determination of the complete genome and functional analysis of HPV6 isolate VBD19/10 from a patient with aggressive recurrent respiratory papillomatosis. (26931553)	Seedat R.Y.... Burt F.J.	2016
9	Multidimensional vocal assessment after laser treatment for recurrent respiratory papillomatosis. (27515839)	Kono T.... Ogawa K.	2016
10	Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity. (27658005)	Tatar E.A.8.... Merati A.L.	2016
11	Prevalence and management of Recurrent Respiratory Papillomatosis (RRP) in the UK: cross sectional study. (27208548)	Donne A.... Powell S.	2016
12	Response to letter to Editor: "The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors" by Michel R. M. San Giorgi et al. (27654254)	Grasso M.... Lawson G.	2016
13	Safety of paediatric day-stay laryngeal surgery for recurrent respiratory papillomatosis. (26857327)	Gruber M.... Mahadevan M.	2016
14	Quality of life of patients with recurrent respiratory papillomatosis. (27861969)	San Giorgi M.R.... Dikkers F.G.	2016
15	Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis (prospective case-control study). (27759910)	FormA!nek M.... ZelenA-k K.	2016
16	The association between gastroesophageal reflux disease and recurrent respiratory papillomatosis: A systematic review. (27113025)	San Giorgi M.R.... Dikkers F.G.	2016
17	Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis. (27188508)	Tjon Pian Gi R.E.... Dikkers F.G.	2016
18	Acoustical and Perceptual Voice Profiling of Children With Recurrent Respiratory Papillomatosis. (26474713)	Verma H.... James M.	2015
19	Age of onset of Recurrent Respiratory Papillomatosis: a distribution analysis. (26460806)	San Giorgi M.... Dikkers F.G.	2015
20	Molecular subtypification of human papillomavirus in male adult individuals with recurrent respiratory papillomatosis. (25906915)	GarcA-a-Romero C.S.... Coral-VA!zquez R.M.	2015
21	Recurrent respiratory papillomatosis of the airway: The experience of an endoscopic unit. (25926371)	Correia S.... da Costa J.D.	2015
22	Recurrent respiratory papillomatosis: current and future perspectives. (25999724)	Carifi M.... Dall'Olio D.	2015
23	Recurrent respiratory papillomatosis progressing into squamous cell carcinoma in an HIV-positive patient. (26153613)	Barsky M.... Bhora F.Y.	2015
24	Nucleotide and phylogenetic analysis of human papillomavirus type 11 isolated from juvenile-onset recurrent respiratory papillomatosis in China. (26369639)	Xiao Y.... Yang M.	2015
25	Viral load and mRNA expression of HPV type 6 among cases with recurrent respiratory papillomatosis. (26010342)	Forslund O.... Rydell R.	2015
26	Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis. (26151558)	Measso do Bonfim C.... Sichero L.	2015
27	FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung. (26204210)	Tatci E.... Ozmen O.	2015
28	Recurrent respiratory papillomatosis in northern Sweden: clinical characteristics and practical guidance. (26004132)	Loizou C.... Olofsson K.	2015
29	Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population. (26453486)	Karatayli-Ozgursoy S.... Best S.R.	2015
30	Trends in the management of recurrent respiratory papillomatosis in Japan. (25454156)	Murono S.... Yoshizaki T.	2014
31	Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia. (24918765)	Omland T.... ndbo K.	2014
32	Clinical course of recurrent respiratory papillomatosis: Comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. (24955561)	Tjon Pian Gi R.E.... Schuuring E.M.	2014
33	Malignant degeneration of pulmonary juvenile-onset recurrent respiratory papillomatosis. (25487719)	Knepper B.R.... Braithwaite K.A.	2014
34	Diagnosis and management of recurrent respiratory papillomatosis. (25229272)	Wilcox L.J.... Derkay C.S.	2014
35	Natural History and Malignant Transformation in Recurrent Respiratory Papillomatosis: Human Papillomavirus (HPV), Dysplasia and an Autopsy Review. (25353697)	Can N.T.... Taxy J.B.	2014
36	The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors. (25351501)	San Giorgi M.R.... Dikkers F.G.	2014
37	Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: A preliminary study. (25059492)	Born H.... Branski R.C.	2014
38	Pulmonary papillomatosis: a rare case of recurrent respiratory papillomatosis presenting with multiple nodular and cavitary lesions. (25348187)	Martina D.... Pitoyo C.W.	2014
39	Risk factors for adult-onset recurrent respiratory papillomatosis. (24764146)	Ruiz R.... Amin M.R.	2014
40	Voice and quality of life in patients with recurrent respiratory papillomatosis in a northern Sweden cohort. (24433057)	Loizou C.... Olofsson K.	2014
41	A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion. (24942884)	Mauz P.S.... Iftner T.	2014
42	Xenograft Model for Therapeutic Drug Testing in Recurrent Respiratory Papillomatosis. (25124839)	Ahn J.... Best S.R.	2014
43	Chromoendoscopy Associated With Endoscopic Laryngeal Surgery: A New Technique for Treating Recurrent Respiratory Papillomatosis. (24674651)	Rey Caro D.G.... Rey Caro E.A.	2014
44	Adult-Onset Recurrent Respiratory Papillomatosis: A Review of Disease Pathogenesis and Implications for Patient Counseling. (25393901)	Taliercio S.... Branski R.C.	2014
45	Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. (25289079)	Mohr M.... Berdel W.E.	2014
46	Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir. (25762828)	Fusconi M.... de Vincentiis M.	2014
47	Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. (24964770)	HoA8evar-BolteA3ar I.... Zargi M.	2014
48	The incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in the Free State province of South Africa and Lesotho. (25300480)	Seedat R.Y.	2014
49	Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. (24722383)	Marsico M.... Derkay C.	2014
50	Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis. (25391185)	Intakorn P.... Sonsuwan N.	2014

Genes related to Recurrent Respiratory Papillomatosis

Sources:
²¹GeneCards
See all MalaCards sources

Genes related to Recurrent Respiratory Papillomatosis:

- Elite gene

- Cancer Census gene in COSMIC

id	Symbol	Description	Score	Implication
1	HLA-DRB1	Major Histocompatibility Complex, Class II, DR Beta 1	28.76	GeneCards inferred via : Disorders, Publications (show sections)
2	HLA-DQB1	Major Histocompatibility Complex, Class II, DQ Beta 1	28.65	GeneCards inferred via : Disorders, Publications (show sections)
3	IL2	Interleukin 2	28.52	GeneCards inferred via : Disorders, Publications (show sections)
4	EGFR	Epidermal Growth Factor Receptor	28.35	GeneCards inferred via : Disorders, Publications (show sections)
5	IFNA2	Interferon Alpha 2	28.11	GeneCards inferred via : Disorders, Publications (show sections)
6	KIR2DL2	Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Long Cytoplasmic Tail 2	28.11	GeneCards inferred via : Disorders, Publications (show sections)
7	FUT8	Fucosyltransferase 8	28.11	GeneCards inferred via : Disorders, Publications (show sections)

Variations for Recurrent Respiratory Papillomatosis

Expression for genes affiliated with Recurrent Respiratory Papillomatosis

Sources:
¹⁸Gene Expression Omnibus DataSets
See all MalaCards sources

Search GEO for disease gene expression data for Recurrent Respiratory Papillomatosis.

Pathways for genes affiliated with Recurrent Respiratory Papillomatosis

Sources:
³⁴KEGG, ⁴²NCBI BioSystems Database, ⁵⁵PathCards, ⁵⁸QIAGEN, ⁵⁹R&D Systems, ⁶⁰Reactome, ⁶⁵Thomson Reuters
See all MalaCards sources

Pathways related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

(show all 23)

id	Super pathways	Score	Top Affiliating Genes
1	CTLA4 Signaling⁵⁸	9.7	HLA-DQB1, HLA-DRB1
2	Staphylococcus aureus infection³⁴	9.7	HLA-DQB1, HLA-DRB1
3	Cytokines and Inflammatory Response⁴²	9.6	HLA-DRB1, IL2
4	IL12 signaling mediated by STAT4⁴²	9.6	HLA-DRB1, IL2
5	Regulation of Telomerase⁴²	9.5	EGFR, IL2
6	Photodynamic therapy-induced AP-1 survival signaling.⁴²	9.5	EGFR, IL2
7	Aryl Hydrocarbon Receptor Pathway⁴²	9.5	EGFR, IL2
8	Dendritic Cells Developmental Lineage Pathway⁵⁹	9.4	IFNA2, IL2
9	Th17 cell differentiation³⁴ Show member pathways Immune response IL-22 signaling pathway⁶⁵ Inflammatory bowel disease (IBD)³⁴ Th1 and Th2 cell differentiation³⁴ IL-22 Pathway⁵⁸	9.2	HLA-DQB1, HLA-DRB1, IL2
10	ICos-ICosL Pathway in T-Helper Cell⁵⁸ Show member pathways Calcium Mediated T-Cell Apoptosis⁵⁸ CD28 Signaling in T-Helper Cell⁵⁸	9.2	HLA-DQB1, HLA-DRB1, IL2
11	HTLV-I infection³⁴	9.2	HLA-DQB1, HLA-DRB1, IL2
12	Immune response NFAT in immune response⁶⁵ Show member pathways Immune response T cell receptor signaling pathway⁶⁵ Immune response CD28 signaling⁶⁵ Immune response ICOS pathway in T-helper cell⁶⁵	9.2	HLA-DQB1, HLA-DRB1, IL2
13	G-protein signaling N-RAS regulation pathway⁶⁵ Show member pathways Immune response Antigen presentation by MHC class II⁶⁵	9.2	EGFR, HLA-DQB1, HLA-DRB1
14	Interferon gamma signaling⁶⁰ Show member pathways Interferon Signaling⁶⁰ Regulation of IFNG signaling⁶⁰	9.1	HLA-DQB1, HLA-DRB1, IFNA2
15	Tuberculosis³⁴	9.1	HLA-DQB1, HLA-DRB1, IFNA2
16	PI3K-Akt signaling pathway³⁴	8.9	EGFR, IFNA2, IL2
17	Jak/STAT Signaling Pathway⁵⁹	8.9	EGFR, IFNA2, IL2
18	IL-2 Pathway⁵⁸ Show member pathways Prolactin Signaling⁵⁸ PI3K Signaling in B-Lymphocyte⁵⁸ ErbB2-ErbB3 Heterodimers⁵⁸ ErbB Family Pathway⁵⁸ ErbB4 Pathway⁵⁸ HMGB1 Pathway⁵⁸ Thrombopoietin Pathway⁵⁸ TREM1 Pathway⁵⁸ IL-4 Pathway⁵⁸ UVC-Induced MAPK Signaling⁵⁸ LPS Stimulated MAPK Signaling⁵⁸ Growth Hormone Signaling⁵⁸ PACAP Signaling⁵⁸	8.7	EGFR, HLA-DQB1, HLA-DRB1, IL2
19	Influenza A³⁴ Show member pathways Herpes simplex infection³⁴ Measles³⁴	8.6	HLA-DQB1, HLA-DRB1, IFNA2, IL2
20	Immune response Role of DAP12 receptors in NK cells⁶⁵ Show member pathways Immune response CD16 signaling in NK cells⁶⁵ Natural killer cell mediated cytotoxicity³⁴	8.6	IFNA2, IL2, KIR2DL2
21	Cytokine Signaling in Immune system⁶⁰ Show member pathways Signaling by Interleukins⁶⁰	8.1	EGFR, HLA-DQB1, HLA-DRB1, IFNA2, IL2
22	Allograft rejection⁴² ³⁴ Show member pathways Allograft Rejection⁴² Viral myocarditis³⁴ Asthma³⁴ CTL Mediated Apoptosis⁵⁸ Intestinal immune network for IgA production³⁴ Autoimmune thyroid disease³⁴ Type I diabetes mellitus³⁴ Graft-versus-host disease³⁴ Antigen processing and presentation³⁴ THC Differentiation Pathway⁵⁸	7.8	HLA-DQB1, HLA-DRB1, IFNA2, IL2, KIR2DL2
23	Innate Immune System⁶⁰ Show member pathways Immune System⁶⁰ Neutrophil degranulation⁶⁰	7.3	EGFR, HLA-DQB1, HLA-DRB1, IFNA2, IL2, KIR2DL2

GO Terms for genes affiliated with Recurrent Respiratory Papillomatosis

Sources:
¹⁹Gene Ontology
See all MalaCards sources

Cellular components related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

id	Name	GO ID	Score	Top Affiliating Genes
1	clathrin-coated endocytic vesicle membrane	GO:0030669	10.4	HLA-DQB1, HLA-DRB1
2	endocytic vesicle membrane	GO:0030666	10.4	HLA-DQB1, HLA-DRB1
3	ER to Golgi transport vesicle membrane	GO:0012507	10.4	HLA-DQB1, HLA-DRB1
4	integral component of lumenal side of endoplasmic reticulum membrane	GO:0071556	10.2	HLA-DQB1, HLA-DRB1
5	MHC class II protein complex	GO:0042613	10.1	HLA-DQB1, HLA-DRB1
6	endosome membrane	GO:0010008	9.9	EGFR, HLA-DQB1, HLA-DRB1
7	transport vesicle membrane	GO:0030658	9.7	HLA-DQB1, HLA-DRB1
8	Golgi membrane	GO:0000139	9.2	EGFR, FUT8, HLA-DQB1, HLA-DRB1

Biological processes related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

(show all 8)

id	Name	GO ID	Score	Top Affiliating Genes
1	antigen processing and presentation	GO:0019882	10.3	HLA-DQB1, HLA-DRB1
2	antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	GO:0002504	10.3	HLA-DQB1, HLA-DRB1
3	humoral immune response mediated by circulating immunoglobulin	GO:0002455	10.3	HLA-DQB1, HLA-DRB1
4	immunoglobulin production involved in immunoglobulin mediated immune response	GO:0002381	10.3	HLA-DQB1, HLA-DRB1
5	interferon-gamma-mediated signaling pathway	GO:0060333	10.2	HLA-DQB1, HLA-DRB1
6	positive regulation of inflammatory response	GO:0050729	10.0	EGFR, IL2
7	positive regulation of phosphorylation	GO:0042327	9.8	EGFR, IFNA2
8	positive regulation of tyrosine phosphorylation of STAT protein	GO:0042531	9.4	IFNA2, IL2